Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2016 / Cilt: 49 - Sayı: 1

LOCAL RECURRENCE AFTER BREAST CONSERVATIVE SURGERY

MEME KORUYUCU CERRAHİ SONRASI LOKAL NÜKS

Pages
46–54
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, risk factors that contribute to local recurrence, follow up after BCS and treatment options for recurrence were analyzed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast conservative surgery BCS is defined as the excision of tumor with surrounding healthy breast tissue and dissection of axillary lymph nodes.
📊
Key Findings & Data:There is no significant difference between the survival rates of patients who had mastectomy M and BCS.
💡
Conclusion & Impact:In this review, risk factors that contribute to local recurrence, follow up after BCS and treatment options for recurrence were analyzed
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Meme kanseri · lokal nüks · meme koruyucu cerrahi

Abstract

Breast conservative surgery BCS is defined as the excision of tumor with surrounding healthy breast tissue and dissection of axillary lymph nodes. Radiotherapy RT to the remaining breast tissue must be given as a part of the treatment protocol. BCS is a commonly used treatment in the early stages of breast cancer. There is no significant difference between the survival rates of patients who had mastectomy M and BCS. The advantage of BCS over M is better cosmetic and psychological results. The main disadvantage of BCS is higher risk of recurrence in the remaining breast tissue. There are various factors which contribute to local recurrence related to the tumor, patient and treatment. In this review, risk factors that contribute to local recurrence, follow up after BCS and treatment options for recurrence were analyzed

Özet

Meme koruyucu cerrahi MKC , tümörle birlikte çevresinden bir miktar sağlam meme dokusunun çıkartılması ve koltuk altı lenf bezlerinin diseksiyonu işlemlerini içerir. Kalan meme dokusuna radyoterapi RT verilmesi de bu tedavinin bir parçası olarak uygulanmalıdır. MKC erken evre meme kanserinin tedavisinde sıklıkla tercih edilen bir seçenektir. MKC ile memenin tümüyle alınması arasında hastanın yaşam süresi bakımından hiçbir fark yoktur. MKC’nin mastektomiye M olan üstünlüğü, memenin büyük bir bölümünün korunmasını sağladığı için elde edilen daha iyi kozmetik ve psikolojik sonuçtur. Dezavantajı ise geriye kalan meme dokusunda tümörün tekrar etme riskinin biraz daha yüksek olmasıdır. Nüks gelişimine etki eden; tümöre, hastaya ve tedaviye bağlı çeşitli faktörler vardır. Bu derlemede MKC sonrası lokal nüks gelişimine etki eden risk faktörleri, MKC sonrası takip ve nükse yönelik tedavi seçenekleri gözden geçirildi

🔖

Cite This Article

TUNCAL, S., ÖZBALCI, G. S., ÖZBALCI, A. B. (2022). LOCAL RECURRENCE AFTER BREAST CONSERVATIVE SURGERY. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 49 - Sayı: 1, 46–54. https://ajindex.com/articles/441372

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Robinson J.O. Treatment of breast cancer through the ages. Am J Surg. 1986; 151: 317-33. 2)Meric F, Robinson EK, Hunt KK. Noninvasive Breast Cancer. In: Feig BW, Berger DH, Fuhrman GM, eds. The M.D. Anderson Surgical Oncology Handbook. 3rd ed. Houston,Teksas: Lippincott Williams&Wilkins, 2003: 1-13. 3)Onat D. Operable Meme Kanseri Tedavisi. Sayek İ, editör. Temel Cerrahi
  2. Baskı. Ankara: Güneş Kitabevi. 1996: 873-80. 4)Tebra S, Bouguizene S, Bibi M, Boussen H, Khairi H, Bouaouina N. Conserving surgery for breast cancer Tunis Med. 2010; 88: 453-8. 5)Pleijhuis RG, Graafland M, de Vries J, Bart J, de Jong JS, van Dam GM. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 2009; 16: 2717–30. 6)Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E Twenty year follow up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast canser. N Engl J Med. 2002; 347: 1227-32. 7)Newman LA, Washington TA. New Trends in Breast Conservation Therapy. Surg Clin North Am. 2003; 83: 841-83. 8)Müslümanoğlu M. Meme Koruyucu Cerrahi Sonrası Görülen Lokal Nükslerde Cerrahi Yaklaşım. Topuz E, Aydıner A, Dinçer M, editörler. Meme Kanseri
  3. Baskı. İstanbul: Nobel Tıp Kitapevleri. 2003: 471-5. 9)Haffty BG, Carter D, Flynn SD, Fischer DB, Brash DE, Simons J, Ziegler AM, Fischer JJ. Local recurrence versus new primary: Clinical analyses of 82 breast relapses and potential aplications for genetic finger printing. İnt J Radiat Oncol Biol Phys. 1993; 27: 575-83. 10)Francis M, Cakir B, Ung O, Gebski V, Boyages J. Prognosis after breast recurrence following conservative surgery and radiotherapy in patients with node-negative breast canser. Br J Surg.1999; 86: 1556-62. 11)van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J. Factors influencing lokal relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast canser. EORCT trial 10801, Breast conservation compared with mastectomy in TNM stage I and II breast canser. Eur j Canser.1992; 28A: 801-5. 12)van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, Sylvester R, Fentiman IS, van der Schueren E, van Zijl K, Blichert-Toft M, Bartelink H, van Dongen JA. Prognosis after threatment for loco-regional recurrence after m